Studies have shown that the expression of HMGR, as the rate-limiting enzyme of cholesterol synthesis, is significantly increased in both NAFLD and NASH and is independent of whether the subjects are obese or not35. Here, HMGA1 is linked to metabolic dysfunction-associated steatotic liver disease.